192 related articles for article (PubMed ID: 22026397)
1. Management of menorrhagia associated with chemotherapy-induced thrombocytopenia in women with hematologic malignancy.
Bates JS; Buie LW; Woodis CB
Pharmacotherapy; 2011 Nov; 31(11):1092-110. PubMed ID: 22026397
[TBL] [Abstract][Full Text] [Related]
2. Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate.
Meirow D; Rabinovici J; Katz D; Or R; Shufaro Y; Ben-Yehuda D
Cancer; 2006 Oct; 107(7):1634-41. PubMed ID: 16944540
[TBL] [Abstract][Full Text] [Related]
3. Antifibrinolytics in women with menorrhagia.
Philipp CS
Thromb Res; 2011 Feb; 127 Suppl 3():S113-5. PubMed ID: 21262428
[TBL] [Abstract][Full Text] [Related]
4. Medical management of dysfunctional uterine bleeding.
Irvine GA; Cameron IT
Baillieres Best Pract Res Clin Obstet Gynaecol; 1999 Jun; 13(2):189-202. PubMed ID: 10755037
[TBL] [Abstract][Full Text] [Related]
5. The medical management of abnormal uterine bleeding in reproductive-aged women.
Bradley LD; Gueye NA
Am J Obstet Gynecol; 2016 Jan; 214(1):31-44. PubMed ID: 26254516
[TBL] [Abstract][Full Text] [Related]
6. Treatment of idiopathic menorrhagia with tranexamic acid.
Srinil S; Jaisamrarn U
J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S1-6. PubMed ID: 17722310
[TBL] [Abstract][Full Text] [Related]
7. [A multicenter prospective randomized open comparative study on the treatment of ovulatory menorrhagia with tranexamic acid and norethisterone in China].
Zhang YW; He FF; Sun ZY; Li SW; Bi SL; Huang XL; Cao ZS; Lü SL; Lu JL; Zhang ZY; Zhu YM; Huang HF; Miao MH
Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):247-50. PubMed ID: 18843961
[TBL] [Abstract][Full Text] [Related]
8. Uterine artery blood flow parameters in women with dysfunctional uterine bleeding and uterine fibroids: the effects of tranexamic acid.
Lakhani KP; Marsh MS; Purcell W; Hardiman P
Ultrasound Obstet Gynecol; 1998 Apr; 11(4):283-5. PubMed ID: 9618854
[TBL] [Abstract][Full Text] [Related]
9. Oral modified-release tranexamic acid for heavy menstrual bleeding.
Hrometz SL
Ann Pharmacother; 2012; 46(7-8):1047-53. PubMed ID: 22811348
[TBL] [Abstract][Full Text] [Related]
10. Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid.
Kouides PA; Byams VR; Philipp CS; Stein SF; Heit JA; Lukes AS; Skerrette NI; Dowling NF; Evatt BL; Miller CH; Owens S; Kulkarni R
Br J Haematol; 2009 Apr; 145(2):212-20. PubMed ID: 19236375
[TBL] [Abstract][Full Text] [Related]
11. Women and von Willebrand disease: controversies in diagnosis and management.
Kadir RA; Chi C
Semin Thromb Hemost; 2006 Sep; 32(6):605-15. PubMed ID: 16977570
[TBL] [Abstract][Full Text] [Related]
12. Tranexamic acid therapy for heavy menstrual bleeding.
Lumsden MA; Wedisinghe L
Expert Opin Pharmacother; 2011 Sep; 12(13):2089-95. PubMed ID: 21767224
[TBL] [Abstract][Full Text] [Related]
13. Tranexamic acid: a review of its use in the management of menorrhagia.
Wellington K; Wagstaff AJ
Drugs; 2003; 63(13):1417-33. PubMed ID: 12825966
[TBL] [Abstract][Full Text] [Related]
14. Therapies for the treatment of abnormal uterine bleeding.
Robins JC
Curr Womens Health Rep; 2001 Dec; 1(3):196-201. PubMed ID: 12112970
[TBL] [Abstract][Full Text] [Related]
15. OTC tranexamic acid for heavy menstrual bleeding?
Drug Ther Bull; 2011 Jan; 49(1):6-8. PubMed ID: 21220253
[TBL] [Abstract][Full Text] [Related]
16. Management of menorrhagia in women with inherited bleeding disorders: general principles and use of desmopressin.
Rodeghiero F
Haemophilia; 2008 Jan; 14 Suppl 1():21-30. PubMed ID: 18173691
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of menorrhagia.
Hurskainen R; Grenman S; Komi I; Kujansuu E; Luoto R; Orrainen M; Patja K; Penttinen J; Silventoinen S; Tapanainen J; Toivonen J
Acta Obstet Gynecol Scand; 2007; 86(6):749-57. PubMed ID: 17520411
[TBL] [Abstract][Full Text] [Related]
18. [Treatment by tranexamic acid in menorrhagia in women using intrauterine devices].
Bengtsson LP; Weström L
Lakartidningen; 1971 Aug; 68(33):3685-91. PubMed ID: 5129410
[TBL] [Abstract][Full Text] [Related]
19. [Update on current care guidelines: evaluation and treatment of menorrhagia].
Duodecim; 2010; 126(8):913-4. PubMed ID: 20597336
[TBL] [Abstract][Full Text] [Related]
20. A dose-response study of a novel, oral tranexamic formulation for heavy menstrual bleeding.
Freeman EW; Lukes A; VanDrie D; Mabey RG; Gersten J; Adomako TL
Am J Obstet Gynecol; 2011 Oct; 205(4):319.e1-7. PubMed ID: 21777897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
